BSECompany Update2 Nov 2026 · 2 Nov 2026, 05:00 pm
Please find enclosed herewith unaudited financial results for the quarter and half year ended on 30th September 2026.
Genomic Valley Biotech Ltd · 539206
✦ AI SummaryResults
Genomic Valley Biotech Ltd has published unaudited financial results for the quarter and half year ended on 30th September 2026, as per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
5c078f78-5da8-4b93-9032-1f95d4feb162.pdf
View document text
Dated:- 02-11-2026
BSE Limited,
Department of Corporate Services,
PJ Towers, Dalal Street,
Mumbai-400001
Company Symbol: GVBL
Scrip Code: 539206
Sub: Newspaper Advertisement regarding Publication of standalone un-audited financial results of
the Company for the quarter ad half year ended on 30th September 2026
Dear Sir/Madam,
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
please find enclosed the clippings of the newspaper advertisement published in English (Financial
Express) editions and Hindi (Jansatta) Regional Language on 01st September 2026, regarding the un-
audited financial results of the Company for the quarter and half year ended on 30th September, 2026.
This is for the information and records.
Thanking you,
Yours sincerely,
For Genomic Valley Biotech Limited
Yogesh Agrawal
Managing Director
DIN:- 01165288
Encl: As above